Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products; Guidance for Industry - Draft Guidance
NonrulemakingOtherFDA-2026-D-2839-0002
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 1, 2026
- Agency
- Food and Drug Administration (FDA)